A Prescription Drug User Fee Act (PDUFA) target action date for apitegromab has been set for Sept. 22, 2025.

Savannah Technical College is waiving application fees for all programs through March 31.

Review details on how Savannah public school students can access SMF's Explore Pass while the broader public can see the free ...

Seattle City Council President Sara Nelson joined SMN live in the studio to discuss the new bill approved by the council to ...

A multidisciplinary approach, early diagnosis, and comprehensive caregiver education are crucial in effectively managing ...

Novartis' OAV101 IT gene therapy showed positive results in Phase 3 trials for SMA, with data supporting its potential as a ...

The spring months (March-May) are typically the hottest in Mexico City, with temperatures cooling off once the rainy season ...

Scholar Rock will present new Phase 3 SAPPHIRE trial data on apitegromab at the 2025 MDA conference, highlighting efficacy ...

Genolier, 24 March 2025 – Swiss Medical Network (SMN) closed the 2024 financial year with consolidated gross revenues of CHF 812.2 million, up by 5.6% compared to 2023. Net revenue reached CHF 684.9 ...

Today on SMN Gee Scott weighed in on the signing of Cooper Kupp. Listen to Seattle's Morning News w/ Charlie Harger every ...

After bringing Zolgensma to market in 2019 as the first gene therapy for spinal muscular atrophy, Novartis is back with an intrathecal formulation intended for older patients.

Once the CNT Major Case Unit develops the evidence against the drug dealer, they try to take out the entire organization, ...